Potential of Medicinal Plants to Ameliorate Retinopathy Events in Diabetes: A Systematic Review

Diabetic Retinopathy (DR) is one of the most common diabetic complications which can lead to vision loss if left unattended. Medicinal plants are considered as a treatment option for its lesser side effects. Given the overwhelming number of studies on various medicinal plants using different subject...

詳細記述

書誌詳細
出版年:JOURNAL OF YOUNG PHARMACISTS
主要な著者: Yong, Phaik Har; Yii, Shirley Ling Zin; Azzani, Meram; Anbazhagan, Deepa; Ng, Zhi Xiang
フォーマット: Review
言語:English
出版事項: INPHARM ASSOC, PHCOG NET 2024
主題:
オンライン・アクセス:https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001435405500013
author Yong
Phaik Har; Yii
Shirley Ling Zin; Azzani
Meram; Anbazhagan
Deepa; Ng
Zhi Xiang
spellingShingle Yong
Phaik Har; Yii
Shirley Ling Zin; Azzani
Meram; Anbazhagan
Deepa; Ng
Zhi Xiang
Potential of Medicinal Plants to Ameliorate Retinopathy Events in Diabetes: A Systematic Review
Pharmacology & Pharmacy
author_facet Yong
Phaik Har; Yii
Shirley Ling Zin; Azzani
Meram; Anbazhagan
Deepa; Ng
Zhi Xiang
author_sort Yong
spelling Yong, Phaik Har; Yii, Shirley Ling Zin; Azzani, Meram; Anbazhagan, Deepa; Ng, Zhi Xiang
Potential of Medicinal Plants to Ameliorate Retinopathy Events in Diabetes: A Systematic Review
JOURNAL OF YOUNG PHARMACISTS
English
Review
Diabetic Retinopathy (DR) is one of the most common diabetic complications which can lead to vision loss if left unattended. Medicinal plants are considered as a treatment option for its lesser side effects. Given the overwhelming number of studies on various medicinal plants using different subjects, this systematic review aims to update the current status of the potential of medicinal plants in ameliorating DR. Literature from the years 2011 to 2020 was retrieved from PubMed, ScienceDirect and Scopus databases using the search terms: Medicinal plants AND (diabetes OR hyper glycaemia) AND retinopathy. The PRISMA guidelines were adhered to for reporting the systematic review, while the SYRCLE tool was used to assess the risk of bias in animal studies. Inclusion and exclusion criteria were established for selecting compatible studies. Based on these criteria, four out of 439 studies were selected: Studies on DR in rats included three or more assays for measuring retinal vascular permeability, VEGF protein and gene expressions and body weight. An additional six studies from a manual search brought the total to ten selected studies. All studied medicinal plants demonstrated potential in ameliorating DR, based on their downregulation of diabetes-induced retinal vascular leakage and VEGF expressions. Medicinal plants with significant potential in attenuating DR included Zingiber zerumbet rhizomes and its active ingredient, zerumbone; Lycium barbarum; Plantaginis semen; and apocynin. The aqueous extracts of Radix astragali, Radix angelica sinensis, Panax notoginseng, Lycopus lucidus Turcz and total lignans from Fructus arctii can be further evaluated in future studies.
INPHARM ASSOC, PHCOG NET
0975-1483
0975-1505
2024
16
4
10.5530/jyp.2024.16.81
Pharmacology & Pharmacy
gold
WOS:001435405500013
https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001435405500013
title Potential of Medicinal Plants to Ameliorate Retinopathy Events in Diabetes: A Systematic Review
title_short Potential of Medicinal Plants to Ameliorate Retinopathy Events in Diabetes: A Systematic Review
title_full Potential of Medicinal Plants to Ameliorate Retinopathy Events in Diabetes: A Systematic Review
title_fullStr Potential of Medicinal Plants to Ameliorate Retinopathy Events in Diabetes: A Systematic Review
title_full_unstemmed Potential of Medicinal Plants to Ameliorate Retinopathy Events in Diabetes: A Systematic Review
title_sort Potential of Medicinal Plants to Ameliorate Retinopathy Events in Diabetes: A Systematic Review
container_title JOURNAL OF YOUNG PHARMACISTS
language English
format Review
description Diabetic Retinopathy (DR) is one of the most common diabetic complications which can lead to vision loss if left unattended. Medicinal plants are considered as a treatment option for its lesser side effects. Given the overwhelming number of studies on various medicinal plants using different subjects, this systematic review aims to update the current status of the potential of medicinal plants in ameliorating DR. Literature from the years 2011 to 2020 was retrieved from PubMed, ScienceDirect and Scopus databases using the search terms: Medicinal plants AND (diabetes OR hyper glycaemia) AND retinopathy. The PRISMA guidelines were adhered to for reporting the systematic review, while the SYRCLE tool was used to assess the risk of bias in animal studies. Inclusion and exclusion criteria were established for selecting compatible studies. Based on these criteria, four out of 439 studies were selected: Studies on DR in rats included three or more assays for measuring retinal vascular permeability, VEGF protein and gene expressions and body weight. An additional six studies from a manual search brought the total to ten selected studies. All studied medicinal plants demonstrated potential in ameliorating DR, based on their downregulation of diabetes-induced retinal vascular leakage and VEGF expressions. Medicinal plants with significant potential in attenuating DR included Zingiber zerumbet rhizomes and its active ingredient, zerumbone; Lycium barbarum; Plantaginis semen; and apocynin. The aqueous extracts of Radix astragali, Radix angelica sinensis, Panax notoginseng, Lycopus lucidus Turcz and total lignans from Fructus arctii can be further evaluated in future studies.
publisher INPHARM ASSOC, PHCOG NET
issn 0975-1483
0975-1505
publishDate 2024
container_volume 16
container_issue 4
doi_str_mv 10.5530/jyp.2024.16.81
topic Pharmacology & Pharmacy
topic_facet Pharmacology & Pharmacy
accesstype gold
id WOS:001435405500013
url https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001435405500013
record_format wos
collection Web of Science (WoS)
_version_ 1828987785205252096